22.626 articles found

Levodopa-induced dyskinesias detection based on the complexity of involuntary movements.

Chelaru MI, Duval C, Jog M.

J Neurosci Methods · 2009-10-28

DOI: 10.1016/j.jneumeth.2009.10.015PMID: 19878692

The effect of psychotherapy in patients with PD: a controlled study.

Sproesser E, Viana MA, Quagliato EM, de Souza EA.

Parkinsonism Relat Disord · 2009-10-27

DOI: 10.1016/j.parkreldis.2009.08.008PMID: 19864172

Drivable multi-therapy trolley for learning leg movements by patient during e.g. Parkinson's disease, has module connection holders for detachably fastening auxiliary therapy devices and arranged at support table

SKRIVANEK ANTON.

· 2009-10-26

Treatments for neurodegenerative disorders

SHAW PAMELA, MEAD RICHARD, HIGGINBOTTOM ADRIAN, BARBER SIAN.

· 2009-10-23

Mitochondria: a therapeutic target in neurodegeneration.

Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA.

Biochim Biophys Acta · 2009-10-21

DOI: 10.1016/j.bbadis.2009.10.007PMID: 19853657

Levodopa Prodrug Mesylate Hydrate

KARABORNI SAMI, LEUNG MANSHIU, MAO CHEN, THALLADI VENKAT R.

· 2009-10-19

USE OF 4-CYCLOPROPYLMETHOXY-N-(3,5-DICHLORO-1-OXIDOPYRIDIN -4-YL)-5-(METHOXY)PYRIDINE-2-CARBOXAMIDE FOR THE TREATMENT OF MOTOR DISORDERS RELATED TO PARKINSON'S DISEASE.

RAVINET-TRILLOU CHRISTINE, DELAY-GOYET PHILIPPE, DELGORGE CLAIRE, MENET CHRISTINE, POUGHON GILLES.

· 2009-10-19

A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease.

Fitzpatrick L, Simpson J, Smith A.

Psychol Psychother · 2009-10-19

DOI: 10.1348/147608309x471514PMID: 19843353

Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS.

Lim ST, Airavaara M, Harvey BK.

Pharmacol Res · 2009-10-17

DOI: 10.1016/j.phrs.2009.10.002PMID: 19840853

Novel therapeutic strategies in Parkinson's disease.

Klivenyi P, Vecsei L.

Eur J Clin Pharmacol · 2009-10-16

DOI: 10.1007/s00228-009-0742-4PMID: 19834698

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.

Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, Aminoff MJ.

Neurology · 2009-10-14

DOI: 10.1212/wnl.0b013e3181c29356PMID: 19828868

DI-VANILLOYL AND TRI-VANILLOYL DERIVATIVES FOR USE IN ANTI-CANCER THERAPY

KISS ROBERT, DUBOIS JACQUES, NEVE JEAN, LAMORAL-THEYS DELPHINE, DUFRASNE FRANCOIS, POTTIER LAURENT.

· 2009-10-13